Journal ofthe Royal Society ofMedicine Volume 73 September 1980 Homografts in the middle earl Homograft materials have been in use in the middle ear for over 20 years and during that time a substantial amount of understanding has been developed. However there are still large areas where our knowledge is only superficial.
The results of tympanoplasty using homografts have been very encouraging. Indeed, the middle ear reaction has been so mild that it has been suggested that it is a privileged site, comparable to the cornea or the brain. In support of this is the observation that a homologous ossicle is well tolerated when transplanted orthotopically but rejected after ectopic transplantation. However, there is no suggestion ofprivilege when a xenograft is transplanted into the middle ear. It is promptly rejected.
In a recent paper presented at a meeting of the Section of Otology, Kuijpers & Veldman (1980) demonstrated that the ear is not a privileged site. Using rats, presensitized by skin grafts two weeks prior to ossicular transplantation, there were clear signs of rejection of homologous ossicles in the middle ear. They reported the impression that the reaction was less marked when the grafts were preserved in alcohol or Cialit, than when fresh or preserved in formaldehyde.
There is no good reason why the ear should be a privileged site and this experiment confirms what logic would suggest. Presumably the minor nature of reactions to homografts in the middle ear is related to the low antigenicity of the structures transplanted and the small degree of contact in the normally aerated middle ear cavity.
There has never been much dispute about homograft ossicles in the middle ear, which are widely used in clinical practice. Studies of transplanted ossicles in animals show rapid replacement by new bone, a process which has been called 'creeping substitution'. In humans the amount of new bone laid down is variable. In some there is an impression that, eventually, the homograft will be replaced by the patient's own tissue, and in others new bone is limited to minute amounts in one or two areas. Even where there is little or no new bone the macroscopic appearance ofthe homograft is usually preserved.
Cartilage also has shown itself to be fairly reliable. However, the firm nature of transplanted nasal cartilage is not always maintained and after a few years in the middle ear it may feel like soft rubber, so that doubt has been expressed about its sound conducting properties.
Homologous fascia and dura have been shown to give success rates comparable to those achieved with autologous temporalis fascia in repair of the tympanic membrane.
There have been advocates of homograft transplantation of the tympanic membrane and, in some cases, monobloc transplantation of the membrane and ossicles, but these transplants have never gained universal acceptance. One problem is their availability. However, the main problem is probably the difficulty others have had in achieving the success rate claimed by those who advocate these grafts. Even in the best hands the take rate of homograft tympanic membranes is rarely as good as that obtained with autologous fascia or homologous dura, and it often is a lot worse. There was much enthusiasm for these grafts ten years ago, but many who used them then have stopped doing so and it is difficult to get convincing evidence that these should be used in preference to other tissues.
There is no doubt that, where a homologous tympanic membrane transplant has been used, the appearance is very pleasing at the conclusion of an operation. The end result may be a thinner, more physiological, tympanic membrane than with other grafts but it also may be a tympanic membrane that is much too thin or even perforated. There has been a lot of loose talking and thinking about tympanic membrane homografts and it is doubtful if there are any situations where they give consistently better results. The failure of drum grafting materials usually results from the problems of the tympanoplasty operation and not the nature of the graft.
Recently the safety of transplants has been brought into question. Rabies and Jakob-Creutzfeldt disease have been reported following corneal grafting. Hepatitis is a risk in all transplant procedures and the virus of hepatitis is difficult to kill without damage to the tissue. Therefore, we must confirm that the graft donor is free from latent viral infections. Homografts should be taken only from suitable donors, where we can be sure there was no neurological illness or malignant disease. The blood must also be checked to ensure freedom from hepatitis virus.
In conclusion, homografts have an important place in tympanoplasty and are safe, providing certain precautions are taken. In the past our approach has often been unscientific. More carefully planned research and prolonged follow up of patients with homografts are required before we can expect any final answers to some of the problems that still perplex us.
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